First study of heart 'maps' for kids could help correct rapid rhythms

July 23, 2012

The first study of a procedure to make three-dimensional "maps" of electrical signals in children's hearts could help cardiologists correct rapid heart rhythms in young patients, according to new research presented at the American Heart Association's Basic Cardiovascular Sciences 2012 Scientific Sessions.

Children with the condition atrioventricular nodal reentrant tachycardia, or AVNRT, suffer from disruptions in the heart's electrical system that cause sudden rapid . Patients have been successfully treated with cardiac ablation , in which the that causes the condition is destroyed by freezing (cryoablation).

It can be a difficult procedure because every patient may have a different area of abnormal tissue causing the arrhythmia, so low-voltage mapping is used to create a profile of high- and low-voltage areas of tissue to guide ablation. However, no research has been done on children until now.

"This is the first study to look at this technique in ," said Lindsey Malloy, D.O., lead researcher and a cardiology fellow and researcher at University of Iowa Children's Hospital in Iowa City. "It has the potential to improve ablation success rates."

Malloy and her colleagues created three-dimensional voltage maps of the right atrium (upper chamber of the heart), using electrical recordings from inside the heart. They also identified a bridge of low voltage signals surrounded by even lower voltage tissue, a "saddle", or voltage bridge indicating where there was reduced .

Twenty-nine patients between the ages of 7 and 20 were included in the study.

Physicians performed guided cryoablation of the abnormal electrical pathway using the bridge identified by voltage mapping. In 25 of 29 patients, there was an adequate voltage bridge to allow guided ablation, while the successful ablation site was within the first three lesions in 15 out of 25 patients.

"This use of voltage-guided mapping of this voltage bridge in AVNRT appears to be both safe and very effective in children while providing for more precise electrically guided ablation," Malloy said.

Explore further: Mount Sinai first to use visually guided catheter ablation system to treat AFib patient

Related Stories

Mount Sinai first to use visually guided catheter ablation system to treat AFib patient

February 21, 2012
For the first time in a new U.S. clinical trial, researchers at Mount Sinai School of Medicine have used the HeartLight Endoscopic Ablation System (EAS) to correct abnormal electrical signals inside the heart of a patient ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.